相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum elafin as a potential inflammatory marker in psoriasis
Ibrahim Elgharib et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2019)
Exosome-Induced Regulation in Inflammatory Bowel Disease
Huiting Zhang et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Mesenteric Fat and Intestinal Muscle Interface: Creeping Fat Influencing Stricture Formation in Crohn's Disease
Ren Mao et al.
INFLAMMATORY BOWEL DISEASES (2019)
Intestinal fibrosis
Marco Vincenzo Lenti et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Predicting Hospitalization and Outpatient Corticosteroid Use in Inflammatory Bowel Disease Patients Using Machine Learning
Akbar K. Waljee et al.
INFLAMMATORY BOWEL DISEASES (2018)
An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease
F. Rieder et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease
Silvio Danese et al.
GASTROENTEROLOGY (2018)
Crohn's disease associated strictures
Webber Pak Wo Chan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications
Daniel Muthas et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
Serum alarm antiproteases in systemic sclerosis patients
Anna Olewicz-Gawlik et al.
HUMAN IMMUNOLOGY (2017)
Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease
Wei Zhang et al.
INFLAMMATORY BOWEL DISEASES (2017)
Machine Learning-Based Gene Prioritization Identifies Novel Candidate Risk Genes for Inflammatory Bowel Disease
Ofer Isakov et al.
INFLAMMATORY BOWEL DISEASES (2017)
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
Subra Kugathasan et al.
LANCET (2017)
CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathway
Chunlan Xu et al.
SCIENTIFIC REPORTS (2017)
Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease
Diana Hoang-Ngoc Tran et al.
BMC GASTROENTEROLOGY (2017)
Assessment of stricturing Crohn's disease: Current clinical practice and future avenues
Dominik Bettenworth et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Biomarkers of intestinal fibrosis - one step towards clinical trials for stricturing inflammatory bowel disease
Paolo Giuffrida et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2016)
C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis
Mahmoud H. Mosli et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Visceral Adipose Tissue in Patients with Crohnʼs Disease Correlates with Disease Activity, Inflammatory Markers, and Outcome
Carsten Büning et al.
INFLAMMATORY BOWEL DISEASES (2015)
Antifibrogenic Effects of the Antimicrobial Peptide Cathelicidin in Murine Colitis-Associated Fibrosis
Jun Hwan Yoo et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Substance P Mediates Proinflammatory Cytokine Release From Mesenteric Adipocytes in Inflammatory Bowel Disease Patients
Aristea Sideri et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Antimicrobial Proteins in Intestine and Inflammatory Bowel Diseases
Jung Mogg Kim
INTESTINAL RESEARCH (2014)
Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project
Isabelle Cleynen et al.
GUT (2013)
The antimicrobial peptide cathelicidin modulates Clostridium difficile-associated colitis and toxin A-mediated enteritis in mice
Tressia C. Hing et al.
GUT (2013)
The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes
Alessia Gallo et al.
PLOS ONE (2012)
Therapeutic potential of human elafin
Lee Shaw et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2011)
Ratio of Visceral to Subcutaneous Fat Area Is a Biomarker of Complicated Crohn's Disease
Bara Erhayiem et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Cathelicidin Signaling via the Toll-like Receptor Protects Against Colitis in Mice
Hon Wai Koon et al.
GASTROENTEROLOGY (2011)
Elafin Is a Biomarker of Graft-Versus-Host Disease of the Skin
Sophie Paczesny et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
Accumulation of elafin in actinic elastosis of sun-damaged skin: Elafin binds to elastin and prevents elastolytic degradation
Jun Muto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease
Michael Schmid et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Relationship between fecal lactoferrin and inflammatory bowel disease
Jun Dai et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)
Defensins and cathelicidins in gastrointestinal infections
Jan Wehkamp et al.
CURRENT OPINION IN GASTROENTEROLOGY (2007)
Detection of elafin as a candidate biomarker for ulcerative colitis by whole-genome microarray screening
Carl-Fredrik Flach et al.
INFLAMMATORY BOWEL DISEASES (2006)
Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases
Juergen Schauber et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2006)
Human β-defensin 2 but not β-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease
J Wehkamp et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
Possible involvement of neutrophil elastase in impaired mucosal repair in patients with ulcerative colitis
Y Kuno et al.
JOURNAL OF GASTROENTEROLOGY (2002)
Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease
E Louis et al.
GUT (2001)
分享论文
